Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Medtronic Genetic Arrhythmia Markers for Early Detection

NCT00664807 is registered in ClinicalTrials.gov with Medtronic Corporate Technologies and New Ventures as lead sponsor.

NCT NCT00664807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00664807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Medtronic Genetic Arrhythmia Markers for Early Detection
Lead sponsor
Medtronic Corporate Technologies and New Ventures
Phase
Observational
Overall status
Completed
Start date
April 30, 2008
Completion date
May 31, 2009
Enrollment
1,023 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, death, sudden, cardiac, sick sinus syndrome, tachycardia, ventricular fibrillation